Antimicrobial resistance (AMR) represents a critical challenge worldwide, necessitating the pursuit of novel approaches to counteract bacterial and fungal pathogens. In this context, we explored the potential of cationic amino acid-enriched short peptides, synthesized via solid-phase methods, as innovative antimicrobial candidates. Our comprehensive evaluation assessed the antibacterial and antifungal efficacy of these peptides against a panel of significant pathogens, including Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pyogenes, Candida albicans, and Aspergillus niger. Utilizing molecular docking techniques, we delved into the molecular interactions underpinning the peptides' action against these microorganisms. The results revealed a spectrum of inhibitory activities, with certain peptide sequences displaying pronounced effectiveness across various pathogens. These findings underscore the peptides' potential as promising antimicrobial agents, with molecular docking offering valuable insights into their mechanisms of action. This study enriches antimicrobial peptide (AMP) research by identifying promising candidates for further refinement and development toward therapeutic application, highlighting their significance in addressing the urgent issue of AMR.
In present work, one-pot synthesis of some new 2,4-disubstitued thiazolyl pyrazole derivatives was carried out. The reaction of different pyrazole 4-carbalaldehydes, thiosemicarbazides and α-haloketones in one pot afforded the target molecules. The synthesis was carried out via two methods: one conventional method, whereby pyrazole 4-carbaldehydes, thiosemicarbazides, and α-haloketones were refluxed in ethanol; and a second way, where the reaction mixture was ground at RT. The rate of the reaction, yield of the products, and purity of the products were compared for both methods. All of the synthesized compounds were tested for their antimicrobial activities. It was found that most of the compounds showed good-to-moderate antibacterial as well as antifungal activities.
The emergence of multidrug-resistant (MDR) pathogens has intensified the need for novel antimicrobial agents. This study focuses on the design, synthesis, and evaluation of hybrid peptides (6a–6e) incorporating unnatural amino acids featuring enhanced hydrophobic side chains. These peptides, particularly 6e, demonstrated potent antimicrobial efficacy. Molecular docking identified the robust binding affinities of peptides 6e and 6b towards the transglycosylase domain of Escherichia coli PBP1b, indicating their potential as enzyme inhibitors. Molecular dynamics (MD) simulations confirmed the stability of peptide-protein complexes over a 100 ns timespan, supporting the structural integrity of peptide 6e. Experimental data further validated computational predictions, with peptide 6e exhibiting minimum inhibitory concentrations (MICs) as low as 2 µg mL−1 against E. coli and 0.2 µg mL−1 against Bacillus subtilis. Additionally, 6e demonstrated broad-spectrum antifungal efficacy, showing competitive activity against Candida albicans and Aspergillus niger. These results establish unnatural amino acid-based peptides as promising candidates in addressing MDR infections, warranting further studies for clinical application.
Environmental pollution crisis, particularly mercury ions (Hg2+) contamination, seriously threatens the health of all living organisms. Many studies have shown that even extremely low concentrations of Hg2+ can rigorously damage living organisms. Therefore, it is very much needed for real-time detection of Hg2+. To tackle mercury contamination and for its detection, we herewith proposed an intelligent design of a new fluorescent ‘turn-on’ probe, which was prepared based on the mercury-promoted hydrolysis of vinyl ether moiety. The probe rapidly reacted with mercury ions and showed good selectivity over other metal ions.
In the present work, the synthesis and antimicrobial activity of new thiazole substituted 1,3,4-oxadiazole derivatives was achieved. The reaction of different thioamides with ethyl 4-chloro-3-oxobutanoate (4-chloro ethyl acetoacetate) provided ethyl 2-(2-arylthiazol-4yl)acetate, which on subsequent reaction with hydrazine hydrate in absolute ethanol afforded 2-(2-arylthiazol-4-yl)acetohydrazide. 2-(2-arylthiazol-4-yl)acetohydrazide, on reaction with CS2 and KOH in aqueous ethanol, cyclized to form 5-((2-arylthiazol-4-yl)methyl)-1,3,4-oxadiazole-2-thiol. Finally, 5-((2-arylthiazol-4-yl)methyl)-1,3,4-oxadiazole-2-thiol was further treated with α-halo ketones at room temperature to achieve the target compounds. Most of the compounds showed good antibacterial activity, as well as antifungal activity.